Syndax Pharmaceuticals Inc (SNDX) stock
SNDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 3/30
$8.56−0.64 (-6.96%)
Close on Nov 18, 2026Market cap $764.38MP/E –Yield –
Syndax Pharmaceuticals pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Syndax Pharmaceuticals's pe ratio was 72.4× on Jul 29, 2022, against 4.0× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Jul 29, 2022 | 72.4× | +54.7 |
| 2019 | Oct 31, 2019 | 17.7× | +14.5 |
| 2018 | Dec 31, 2018 | 3.2× | – |
See a number that looks wrong?